Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case–control study

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Anders Olsson, John J.V. McMurray, G Thorgeirsson et al. · The Lancet · 1994 · 8.5K citations

Medicine, Cardiology, Pharmacotherapy +13

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

James Shepherd, Stuart M. Cobbe, Ian Ford et al. · New England Journal of Medicine · 1995 · 7.5K citations · Full text

Medicine, Cardiology, Pharmacotherapy +12

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Paul M. Ridker, Francisco Antônio Helfenstein Fonseca, Jacques Genest et al. · New England Journal of Medicine · 2008 · 6.6K citations · Full text

Medicine, Cardiology, Pharmacotherapy +10

Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

Paul M. Ridker, Francisco Antônio Helfenstein Fonseca, Jacques Genest et al. · Obstetrical & Gynecological Survey · 2009 · 3.7K citations

Medicine, Cardiology, Pharmacotherapy +10

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

The Lancet · 2005 · 3.3K citations

Medicine, Internal Medicine, Pharmacology +13